Frankenfield Christopher James

Insider profile

Frankenfield Christopher James's trades of Xilio Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-01-05 2026-01-02 PlS Planned sale
3,996 -43.9%
87.84
US$1,975,684
3,996 -43.9% 87.84 US$1,975,684
2025-01-03 2025-01-02 PlS Planned sale
91,890 +22.4%
456.38
US$784,019
91,890 +22.4% 456.38 US$784,019